Citadel Advisors’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,915
| Closed | -$22K | – | 6589 |
|
|
2025
Q1 | $22K | Sell |
12,915
-12,849
| -50% | -$21.8K | ﹤0.01% | 5569 |
|
|
2024
Q4 | $57.2K | Buy |
25,764
+8,525
| +49% | +$18.9K | ﹤0.01% | 5423 |
|
|
2024
Q3 | $46K | Buy |
+17,239
| New | +$46K | ﹤0.01% | 5140 |
|
|
2022
Q2 | – | Sell |
-1,842
| Closed | -$12K | – | 6612 |
|
|
2022
Q1 | $12K | Sell |
1,842
-4,504
| -71% | -$29.3K | ﹤0.01% | 6200 |
|
|
2021
Q4 | $41K | Sell |
6,346
-1,833
| -22% | -$11.8K | ﹤0.01% | 6207 |
|
|
2021
Q3 | $114K | Sell |
8,179
-3,211
| -28% | -$44.8K | ﹤0.01% | 5778 |
|
|
2021
Q2 | $211K | Buy |
11,390
+7,621
| +202% | +$141K | ﹤0.01% | 5529 |
|
|
2021
Q1 | $88K | Buy |
3,769
+1,184
| +46% | +$27.6K | ﹤0.01% | 5919 |
|
|
2020
Q4 | $48K | Sell |
2,585
-2,614
| -50% | -$48.5K | ﹤0.01% | 4855 |
|
|
2020
Q3 | $132K | Sell |
5,199
-2,239
| -30% | -$56.8K | ﹤0.01% | 4191 |
|
|
2020
Q2 | $215K | Buy |
7,438
+2,421
| +48% | +$70K | ﹤0.01% | 4031 |
|
|
2020
Q1 | $242K | Buy |
5,017
+1,487
| +42% | +$71.7K | ﹤0.01% | 3944 |
|
|
2019
Q4 | $201K | Sell |
3,530
-4,068
| -54% | -$232K | ﹤0.01% | 4135 |
|
|
2019
Q3 | $471K | Sell |
7,598
-1,747
| -19% | -$108K | ﹤0.01% | 3518 |
|
|
2019
Q2 | $420K | Sell |
9,345
-4,477
| -32% | -$201K | ﹤0.01% | 3654 |
|
|
2019
Q1 | $869K | Buy |
13,822
+2,242
| +19% | +$141K | ﹤0.01% | 2951 |
|
|
2018
Q4 | $625K | Buy |
11,580
+1,495
| +15% | +$80.7K | ﹤0.01% | 3127 |
|
|
2018
Q3 | $1.01M | Buy |
+10,085
| New | +$1.01M | ﹤0.01% | 2707 |
|
|
2017
Q3 | – | Sell |
-4,999
| Closed | -$354K | – | 3953 |
|
|
2017
Q2 | $354K | Buy |
4,999
+3,309
| +196% | +$234K | ﹤0.01% | 2796 |
|
|
2017
Q1 | $110K | Buy |
+1,690
| New | +$110K | ﹤0.01% | 3308 |
|